Erica Dommasch is a Dermatology physician affiliated with Harvard University. OpenAlex indexes 52 publications with 1,524 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Shapiro 2
Boston, MA 022155400
Telephone
617-667-3753Registry record last updated 20 Mar 2015.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Botanix SB IncProgram year20252 payments
- Janssen Biotech, Inc.Program year20253 payments
- Incyte CorporationProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
32.7%Corticosteroid9%Triamcinolone Acetonide100%Part D≥63 patientsalpha-Hydroxy Acid8.9%Ammonium Lactate100%Part D≥54 patients+ 5 more classes in this area
Anti-infectives
25.7%Azole Antifungal14.5%Ketoconazole100%Part D≥54 patientsNitroimidazole Antimicrobial6%Metronidazole100%Part D≥35 patients+ 2 more classes in this area
Sensory organs
16%Corticosteroid16%Betamethasone Diprop Augmented46%Clobetasol Propionate42%Betamethasone Dipropionate12%Part D≥50 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 0343 Mental health outcomes of isotretinoin for acne in transgender and gender diverse patients receiving testosterone compared to cisgender patients
Journal of Investigative Dermatology
2025 - 52314 Isotretinoin for Management of Acne in Transgender Persons Receiving Masculinizing Hormone Therapy: A Multicenter Case Series
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”